ASCEND BY NTHRYS
Research Abroad Products

Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 210 project topics
Heart Failure Therapeutic Combination Screening Engine
High-throughput computational tool identifying synergistic drug combinations for heart failure using protein interaction networks and patient stratification algorithms. Accelerates fixed-dose combination development strategies, creating new intellectual property opportunities and expanding addressable markets by 30-50%.
Cardiovascular Pharmacology Drug Development Click to view more details →
Acute Coronary Syndrome Biomarker Integration Platform
Integrated diagnostics and therapeutics platform correlating novel ACS biomarkers with drug response predictions using real-world evidence databases. Enables companion diagnostic development and patient stratification strategies that support premium pricing, exclusivity extensions, and market differentiation.
Cardiovascular Pharmacology Drug Development Click to view more details →
Anticoagulation Therapy Pharmacogenomics Decision Support Tool
Clinical decision support SaaS integrating genetic testing, patient characteristics, and drug interaction data for personalized anticoagulant dosing recommendations. Improves patient compliance, reduces adverse events, and creates recurring revenue through per-patient licensing and integration partnerships with healthcare systems.
Cardiovascular Pharmacology Drug Development Click to view more details →
Lipid-Lowering Drug Development Bioanalytical Automation Platform
Laboratory information management system automating sample processing, HPLC analysis, and pharmacokinetic parameter calculation for statins and novel lipid modulators. Reduces assay turnaround time by 50%, decreases analytical costs per sample, and accelerates IND submissions by 6-12 months.
Cardiovascular Pharmacology Drug Development Click to view more details →
Pulmonary Hypertension Clinical Trial Patient Recruitment AI
Predictive analytics platform identifying and engaging eligible pulmonary hypertension patients through electronic health record mining and real-world claims data. Reduces patient enrollment timelines by 35%, lowers recruitment costs per subject by 40%, and improves trial retention metrics significantly.
Cardiovascular Pharmacology Drug Development Click to view more details →
Cardiovascular Drug Patent Landscape Intelligence and Strategy Tool
Competitive intelligence platform analyzing patent filings, expiration dates, and freedom-to-operate risks across cardiovascular therapeutic classes. Guides R&D portfolio prioritization, identifies white space opportunities, and supports strategic licensing negotiations saving 20-30% in development resource allocation.
Cardiovascular Pharmacology Drug Development Click to view more details →
AI-Powered Blood-Brain Barrier Permeability Prediction Engine
A SaaS platform that uses machine learning algorithms to predict compound BBB penetration properties before synthesis, significantly reducing failed candidates in preclinical development. This tool enables pharmaceutical companies to accelerate lead optimization timelines by 40-60% while reducing R&D costs by millions per program.
CNS Pharmacology Drug Discovery Platforms Click to view more details →
High-Throughput CNS Target Validation and Screening Platform
An integrated screening service combining automated patch-clamp electrophysiology, calcium imaging, and neuronal assays to validate CNS targets at industrial scale. The platform enables clients to de-risk target selection and generate bankable IND-enabling data, creating recurring SaaS revenue through usage-based licensing models.
CNS Pharmacology Drug Discovery Platforms Click to view more details →
Predictive ADMET Modeling for CNS Drug Candidates Platform
A computational chemistry SaaS tool that integrates ADMET predictions with CNS-specific property assessments including transporters, metabolic stability, and protein binding. Revenue streams include per-compound analysis fees, enterprise licensing for pharma partners, and premium tiers offering real-time API integration with internal chemistry platforms.
CNS Pharmacology Drug Discovery Platforms Click to view more details →
CNS-Focused Lead Optimization and Chemical Series Expansion Software
A cloud-based platform combining structure-activity relationship mining, molecular design algorithms, and IP landscape analysis to guide medicinal chemistry decisions in CNS programs. The platform drives value through faster optimization cycles, reduced attrition rates, and actionable insights that reduce time-to-candidate selection by 6-12 months.
CNS Pharmacology Drug Discovery Platforms Click to view more details →
Neuroinflammation and Neuroimmunology Biomarker Discovery Service
A specialized contract research service using proprietary protein and lipid biomarker assays to identify and validate neuroinflammation signatures in patient populations and preclinical models. This service creates recurring revenue through patient stratification studies, biomarker-driven trial design consulting, and companion diagnostic development partnerships.
CNS Pharmacology Drug Discovery Platforms Click to view more details →
Digital Pathology and Neuroanatomy Imaging Analysis Platform
An AI-enabled software platform for automated analysis of immunohistochemistry, electrophysiology mapping, and in vivo neuroimaging data from CNS efficacy studies using deep learning models. The platform accelerates data interpretation, reduces manual scoring variability, and enables clients to derive toxicology and efficacy readouts faster, supporting regulatory submissions.
CNS Pharmacology Drug Discovery Platforms Click to view more details →